Together, the Feinstein Institute and Battelle created a “neural tourniquet,” a technology that aims to help staunch blood loss through electronic nerve stimulation. The neural tourniquet has anticipated applications in planned surgeries and emergency medicine, as well as on the battlefield.
Additional scenarios in which the neural tourniquet may be applied include the following:
- Surgical teams may someday use the device to reduce blood loss in the operating room during planned surgeries or emergency surgeries.
- First responders could apply the device to trauma victims at accident scenes to slow blood loss.
- Soldiers, prior to missions where they could experience trauma, could use a device to proactively curb blood loss in the event they are wounded.
The neural tourniquet is slated to enter the market in the next three to five years.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
